Establishing a roadmap for therapeutics development for cutaneous neurofibromas

被引:0
|
作者
Verma, S. [1 ]
Wolkenstein, P. [2 ]
Le, L. Q. [3 ]
Lee, J. [4 ]
Widemann, B. [5 ]
Brownell, I. [6 ]
Jarnagin, K. [7 ]
Lavker, R. M. [8 ]
Legius, E. [9 ]
Anderson, R. [10 ]
Plotkin, S. [11 ]
Weinberg, H.
Casey, D. [12 ]
Ko, H. [12 ]
LaRosa, S. [13 ]
Knight, P. [13 ]
Parides, M.
Bora, N. [14 ]
Morris, J. [15 ]
Riccardi, V. [16 ]
Korf, B. [17 ]
Blakeley, J. [1 ]
机构
[1] Johns Hopkins Sch Med, Baltimore, MD USA
[2] Univ Paris XII Val Marne, Paris, France
[3] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[4] Roivant Sci Inc, Durham, NC USA
[5] NCI, Bethesda, MD 20892 USA
[6] NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA
[7] Pfizer, Cambridge, MA USA
[8] Northwestern Univ, Chicago, IL 60611 USA
[9] Univ Leuven, Lueven, Belgium
[10] Wellman Ctr Photomed MGH, Boston, MA USA
[11] Harvard Mass Gen Hosp, Cambridge, MA USA
[12] FDA, Rockville, MD USA
[13] CTF, New York, NY USA
[14] Dept Def, Bethesda, MD USA
[15] NIH, Bethesda, MD 20892 USA
[16] NF Inst, Los Angeles, CA USA
[17] UAB, Birmingham, AL USA
关键词
D O I
10.1016/j.jid.2017.07.025
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
LB951
引用
收藏
页码:B4 / B4
页数:1
相关论文
共 50 条
  • [31] The development of cutaneous neurofibromas is influenced by familial and local factors in patients with Neurofibromatosis 1 (NF1).
    Palmer, C
    Szudek, J
    Joe, H
    Riccardi, VM
    Friedman, JM
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 132 - 132
  • [34] Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1
    Rafaela E. Rozza-de-Menezes
    Nicolle C. Gaglionone
    Raquel M. Andrade-Losso
    Orlando H. K. Siqueira
    Lilian M. Almeida
    Kamila da S. Peruzini
    Marco A. C. Guimarães-Filho
    Carolina I. Brum
    Mauro Geller
    Karin S. Cunha
    Orphanet Journal of Rare Diseases, 12
  • [35] Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1
    Lin, Michelle Jade
    Yao, Hanqi
    Vera, Katya
    Patel, Ekshika
    Johnson, Mandi
    Caroline, Peter
    Ramos, Jeanie
    Mehta, Jasmine
    Hu, Xing
    Blakeley, Jaishri O.
    Romo, Carlos G.
    Sarin, Kavita Y.
    JAMA DERMATOLOGY, 2024, 160 (10) : 1091 - 1098
  • [36] Prevalence and clinicopathological characteristics of lipomatous neurofibromas in neurofibromatosis 1: An investigation of 229 cutaneous neurofibromas and a systematic review of the literature
    Rozza-de-Menezes, Rafaela Elvira
    Ito Brum, Carolina de Almeida
    Gaglionone, Nicolle Cavalcante
    de Sousa Almeida, Lilian Machado
    Andrade-Losso, Raquel Machado
    Barboza Paiva, Brenda Vasconcelos
    Sanches Faveret, Pedro Leonardo
    da Silva, Andre Vallejo
    Kiono Siqueira, Orlando Hiroshi
    Riccardi, Vincent M.
    Cunha, Karin Soares
    JOURNAL OF CUTANEOUS PATHOLOGY, 2018, 45 (10) : 743 - 753
  • [37] Cutaneous Reactions to Novel Therapeutics
    Hoang, Mai P.
    Kroshinsky, Daniela
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2012, 34 (07) : 679 - 690
  • [38] Simple method for estimating cutaneous neurofibromas in patients with neurofibromatosis 1
    Yoshida, Yuichi
    Ehara, Yuko
    Noma, Hiroshi
    Yamamoto, Osamu
    JOURNAL OF DERMATOLOGY, 2018, 45 (05): : 626 - +
  • [39] Validating Advanced Volumetric Techniques for Cutaneous Neurofibromas in Clinical Trials
    Thalheimer, Raquel D.
    Merker, Vanessa L.
    Ly, Ina
    Verma, Sharad K.
    Champlain, Amanda H.
    Sawaya, Jennifer L.
    Askenazi, Naomi L.
    Jordan, Justin T.
    Muzikansky, Alona
    Sakamoto, Fernanda
    Blakeley, Jaishri O.
    Anderson, R. Rox
    Plotkin, Scott R.
    NEUROLOGY, 2019, 92 (15)
  • [40] Status and Recommendations for Incorporating Biomarkers for Cutaneous Neurofibromas Into Clinical Research
    Wallis, Deeann
    Stemmer-Rachamimov, Anat
    Adsit, Sarah
    Korf, Bruce
    Pichard, Dominique
    Blakeley, Jaishri
    Sarin, Kavita Y.
    NEUROLOGY, 2021, 97 (07) : S42 - S49